Literature DB >> 2970290

Efficacy of delayed percutaneous transluminal coronary angioplasty after intravenous use of streptokinase in myocardial infarction.

R M Gagnon1, M Morissette, P Laramée, G Dumont, F Sestier, G Leclerc, E Goudreau.   

Abstract

Between June 1984 and December 1986, 35 patients with acute myocardial infarction received streptokinase intravenously within 3 hours after the beginning of chest pain and underwent percutaneous transluminal coronary angioplasty (PTCA) either immediately (in 2 cases) or 1 to 19 (mean 4.4) days later (in 33). The rate of successful PTCA was 89%. Reocclusion occurred in one patient. The mean percentage of stenosis decreased from 86% to 11%. The mean trans-stenotic gradient was reduced from 41 to 11 mm Hg. The results suggest that in patients whose condition is stable, PTCA performed a few days after thrombolysis is a valuable alternative to more aggressive treatment with immediate PTCA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2970290      PMCID: PMC1268156     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  15 in total

1.  Coronary thrombolysis: second chance therapy--maximizing the advantage.

Authors:  J H Vogel
Journal:  J Am Coll Cardiol       Date:  1986-11       Impact factor: 24.094

2.  Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial.

Authors:  D O Williams; J Borer; E Braunwald; J H Chesebro; L S Cohen; J Dalen; H T Dodge; C K Francis; G Knatterud; P Ludbrook
Journal:  Circulation       Date:  1986-02       Impact factor: 29.690

3.  Percutaneous transluminal coronary angioplasty in evolving acute myocardial infarction.

Authors:  X E Prida; J P Holland; R L Feldman; J A Hill; R G MacDonald; C R Conti; C J Pepine
Journal:  Am J Cardiol       Date:  1986-05-01       Impact factor: 2.778

4.  Usefulness of coronary artery bypass graft surgery or percutaneous transluminal angioplasty after thrombolytic therapy.

Authors:  H T Dodge; F H Sheehan; D G Mathey; B G Brown; J W Kennedy
Journal:  Circulation       Date:  1985-12       Impact factor: 29.690

5.  Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands.

Authors:  M L Simoons; P W Serruys; M vd Brand; F Bär; C de Zwaan; J Res; F W Verheugt; X H Krauss; W J Remme; F Vermeer
Journal:  Lancet       Date:  1985-09-14       Impact factor: 79.321

6.  Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase.

Authors:  G Koren; A T Weiss; Y Hasin; D Appelbaum; S Welber; Y Rozenman; C Lotan; M Mosseri; D Sapoznikov; M H Luria
Journal:  N Engl J Med       Date:  1985-11-28       Impact factor: 91.245

7.  Intravenous streptokinase in evolving acute myocardial infarction.

Authors:  W Ganz; I Geft; P K Shah; A S Lew; L Rodriguez; T Weiss; J Maddahi; D S Berman; Y Charuzi; H J Swan
Journal:  Am J Cardiol       Date:  1984-05-01       Impact factor: 2.778

8.  Incomplete lysis of thrombus in the moderate underlying atherosclerotic lesion during intracoronary infusion of streptokinase for acute myocardial infarction: quantitative angiographic observations.

Authors:  B G Brown; C A Gallery; R S Badger; J W Kennedy; D Mathey; E L Bolson; H T Dodge
Journal:  Circulation       Date:  1986-04       Impact factor: 29.690

9.  A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction.

Authors:  W O'Neill; G C Timmis; P D Bourdillon; P Lai; V Ganghadarhan; J Walton; R Ramos; N Laufer; S Gordon; M A Schork
Journal:  N Engl J Med       Date:  1986-03-27       Impact factor: 91.245

10.  Percutaneous transluminal coronary angioplasty after thrombolytic therapy: a prospective controlled randomized trial.

Authors:  R Erbel; T Pop; K J Henrichs; K von Olshausen; C J Schuster; H J Rupprecht; C Steuernagel; J Meyer
Journal:  J Am Coll Cardiol       Date:  1986-09       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.